Not applicableStudy completedNCT02061345What this trial is testingPET Imaging in MCI Following ADT for PCaWho this might be right forProstate CancerMild Cognitive Impairment Imperial College London 11
Early research (Phase 1)Active Not RecruitingNCT03999164What this trial is testingImaging of Neuro-Inflammation and the Risk for Post-Traumatic EpilepsyWho this might be right forEpilepsy, Post-Traumatic University of California, Davis 30
Testing effectiveness (Phase 2)Study completedNCT02388295What this trial is testingAZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA PatientsWho this might be right forMultiple System Atrophy, MSA AstraZeneca 59
Not applicableUnknownNCT04171882What this trial is testingMicroglial Cells Activation Imaging Using PET-CT With 18F-DPA714Who this might be right forMicroglial Cells Activation Imaging Weibing Miao, PhD 500
Early research (Phase 1)Study completedNCT04233593What this trial is testingNeuroimmune Response to LipopolysaccharideWho this might be right forHealthy Yale University 27
Not applicableActive Not RecruitingNCT05753995What this trial is testingImmuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging StudyWho this might be right forGlioblastoma Kepler University Hospital 20
Very early researchStudy completedNCT05357833What this trial is testingNovel Imaging Markers in SPMSWho this might be right forSecondary Progressive Multiple SclerosisMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis University of Utah 11
Post-approval studies (Phase 4)Study completedNCT04230174What this trial is testingEffect of Ocrelizumab on Neuroinflammation in Multiple Sclerosis as Measured by 11C-PBR28 MR-PET Imaging of Microglia ActivationWho this might be right forMultiple Sclerosis Massachusetts General Hospital 22